Holen Sie sich die Stockscreener-App
10.70
8.23%
-0.96
Handel nachbörslich:
10.42
-0.28
-2.62%
Schlusskurs vom Vortag:
$11.66
Offen:
$11.74
24-Stunden-Volumen:
1.51M
Relative Volume:
0.72
Marktkapitalisierung:
$1.30B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-36.90
EPS:
-0.29
Netto-Cashflow:
$-31.85M
1W Leistung:
+1.90%
1M Leistung:
+8.30%
6M Leistung:
+53.08%
1J Leistung:
+255.48%
1-Tages-Spanne:
$10.67
$11.83
1-Wochen-Bereich:
$10.30
$11.83
52-Wochen-Spanne:
$2.36
$11.83
Trevi Therapeutics Inc Stock (TRVI) Company Profile
Firmenname
Trevi Therapeutics Inc
Sektor
Branche
Telefon
203-304-2499
Adresse
195 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie TRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
10.70 | 1.42B | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-05-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-10 | Bestätigt | Needham | Buy |
| 2025-03-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-30 | Eingeleitet | Raymond James | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-12 | Eingeleitet | B. Riley Securities | Buy |
| 2022-11-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-06-03 | Eingeleitet | Needham | Buy |
| 2019-06-03 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Trevi Therapeutics Inc Aktie (TRVI) Neueste Nachrichten
Using Bollinger Bands to evaluate Trevi Therapeutics Inc.2025 Dividend Review & Community Driven Trade Alerts - newser.com
Momentum divergence signals in Trevi Therapeutics Inc. chartJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Technical signs of recovery in Trevi Therapeutics Inc.2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Applying sector rotation models to Trevi Therapeutics Inc.July 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
Should I hold or sell Trevi Therapeutics Inc. stock in 2025Weekly Trade Report & Technical Confirmation Trade Alerts - newser.com
What MACD signals say about Trevi Therapeutics Inc.Quarterly Investment Review & Intraday High Probability Alerts - newser.com
Will Trevi Therapeutics Inc. stock continue upward momentumJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Does Trevi Therapeutics Inc. show high probability of reboundWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Can Trevi Therapeutics Inc. stock reach $100 price targetWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
What high frequency data says about Trevi Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Analyzing drawdowns of Trevi Therapeutics Inc. with statistical tools2025 Top Decliners & Daily Entry Point Alerts - newser.com
Is now a turning point for Trevi Therapeutics Inc.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Trevi Therapeutics Stock Soars on Clinical Progress and Institutional Backing - AD HOC NEWS
Historical volatility pattern of Trevi Therapeutics Inc. visualizedJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Trevi Therapeutics (NASDAQ:TRVI) Hits New 12-Month HighWhat's Next? - MarketBeat
Trevi Therapeutics stock hits all-time high at 11.11 USD By Investing.com - Investing.com India
Trevi Therapeutics stock hits all-time high at 11.11 USD - Investing.com
Trevi Therapeutics (TRVI) Projected to Post Earnings on Wednesday - MarketBeat
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):